GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zoetis ZTS · USD

Health Care · Pharmaceuticals · US listing · 🇺🇸 United States

S&P 500

Compare

82.32

+3.68%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$9.47bn

FY2016FY2025

Net income

$2.67bn

FY2016FY2025

Free cash flow

$2.28bn

FY2016FY2025

Shareholders' equity

$3.33bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$9.47bn$9.26bn$8.54bn$8.08bn$7.78bn$6.67bn$6.26bn$5.83bn$5.31bn$4.89bn
Gross profit$6.67bn$6.40bn$5.83bn$5.48bn$5.31bn$4.46bn$4.11bn$3.80bn$3.44bn$3.14bn
Research and development$698.0m$686.0m$614.0m$539.0m$508.0m$463.0m$457.0m$432.0m$382.0m$376.0m
Operating income$3.60bn$3.39bn$3.07bn$2.93bn$2.80bn$2.27bn$2.02bn$1.88bn$1.73bn$1.40bn
Net income$2.67bn$2.49bn$2.34bn$2.11bn$2.04bn$1.64bn$1.50bn$1.43bn$864.0m$821.0m
Diluted earnings per share6.095.515.094.534.283.433.122.951.761.65

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$15.47bn$14.24bn$14.29bn$14.93bn$13.90bn$13.61bn$11.54bn$10.78bn$8.59bn$7.65bn
Cash and short-term investments$2.31bn$1.99bn$2.04bn$3.58bn$3.48bn$3.60bn$1.93bn$1.70bn$1.56bn$727.0m
Total liabilities$12.14bn$9.47bn$9.29bn$10.52bn$9.36bn$9.84bn$8.84bn$8.59bn$6.80bn$6.15bn
Debt$9.05bn$6.58bn$6.58bn$7.90bn$6.59bn$7.20bn$6.45bn$6.45bn$4.95bn$4.47bn
Shareholders' equity$3.33bn$4.77bn$5.00bn$4.41bn$4.54bn$3.77bn$2.71bn$2.19bn$1.79bn$1.50bn
Shares outstanding439m451m460m467m476m478m480m484m491m497m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$2.90bn$2.95bn$2.35bn$1.91bn$2.21bn$2.13bn$1.79bn$1.79bn$1.35bn$713.0m
Capital spending−$621.0m−$655.0m−$732.0m−$586.0m−$477.0m−$453.0m−$460.0m−$338.0m−$224.0m−$216.0m
Free cash flow$2.28bn$2.30bn$1.62bn$1.33bn$1.74bn$1.67bn$1.33bn$1.45bn$1.12bn$497.0m
Dividends paid−$889.0m−$786.0m−$692.0m−$611.0m−$474.0m−$380.0m−$314.0m−$243.0m−$206.0m−$188.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$2.47bn$2.26bn$2.39bn$2.40bn$2.46bn$2.22bn$2.32bn$2.39bn
Gross profit$1.79bn$1.62bn$1.64bn$1.69bn$1.78bn$1.57bn$1.58bn$1.65bn
Operating income$937.0m$822.0m$826.0m$936.0m$989.0m$846.0m$765.0m$920.0m
Net income$691.0m$601.0m$603.0m$721.0m$718.0m$631.0m$581.0m$682.0m
Diluted earnings per share1.651.441.371.641.641.441.291.51
Cash from operations$655.0m$401.0m$893.0m$938.0m$486.0m$587.0m$905.0m$951.0m
Capital spending−$117.0m−$110.0m−$161.0m−$133.0m−$178.0m−$149.0m−$216.0m−$167.0m
Free cash flow$538.0m$291.0m$732.0m$805.0m$308.0m$438.0m$689.0m$784.0m
Total assets$15.08bn$15.15bn$15.47bn$15.16bn$14.48bn$14.10bn$14.24bn$14.36bn
Cash and short-term investments$1.68bn$1.94bn$2.31bn$2.08bn$1.44bn$1.72bn$1.99bn$1.71bn
Debt$9.05bn$9.04bn$9.10bn$7.07bn$6.58bn$6.58bn$6.57bn$6.55bn
Shareholders' equity$3.15bn$3.23bn$3.33bn$5.40bn$4.98bn$4.66bn$4.77bn$5.23bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.4%7.2%7.1%
Operating income7.1%9.7%12.8%
Net income8.1%10.3%22.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin69.8%69.0%68.6%67.2%
Operating margin37.3%36.7%36.3%34.1%
Net margin27.6%27.2%26.7%23.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings20.629.638.732.457.048.342.429.040.932.4
Price to sales5.87.910.68.514.911.810.27.16.75.4

Market value over time

31 Oct 2016 to 17 Sept 2026, in USD

$23.80bn$30.50bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-26%-16%38%-39%46%21%61%13%37%12%

Dividends and splits

Per share, in the currency the company pays

Paid for 13 years. Last went ex-dividend on 30 Oct 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.592.031.7961.5571.351.0750.850.692

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.